Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02597543 · ClinicalTrials.gov registry record · Phase 4
Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
A Phase 4 study, sponsored by Paul Kim.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT02597543 is a Phase 4 study that has completed, run by Paul Kim. The registered enrollment target is 14 participants.
The verdict
NCT02597543, a Phase 4 study, has completed, sponsored by Paul Kim.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The investigators will use cardiac MRI to measure the myocardial perfusion reserve and amount of myocardial edema and fibrosis in heart-transplant patients with nonspecific allograft dysfunction in contrast to those with normal graft function. The investigators hypothesize that patients with nonspecific allograft dysfunction will demonstrate decreased myocardial perfusion reserve, related to microvascular allograft vasculopathy, compared to those with normal graft function.
Interventions
- DRUG Gadolinium
- DRUG Regadenoson
- PROCEDURE Cardiac MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02597543
The ClinicalTrials.gov registry entry for NCT02597543 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul Kim, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Gadolinium is the first listed.
NCT02597543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02597543 about?
NCT02597543 is a clinical study titled "Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction". The investigators will use cardiac MRI to measure the myocardial perfusion reserve and amount of myocardial edema and fibrosis in heart-transplant patients with nonspecific allograft dysfunction in contrast to those with normal graft function. The investigators hypothesize that patients with nonspec...
What is the current status of trial NCT02597543?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2015-11. Estimated completion is 2016-06-30.
What interventions are being tested in trial NCT02597543?
The interventions under investigation include: Gadolinium (DRUG), Regadenoson (DRUG), Cardiac MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02597543?
This trial is sponsored by Paul Kim, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.